mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-11 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-08 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
1e-07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-07 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.22 |
5e-07 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-07 |